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Abstract
Background: The effects of an omega-3 (n-3) fatty acid enriched diet alone and in combination
with gamma irradiation (IR) therapy in nude mice bearing a human MDA-MB231 breast cancer
xenograft were tested. The cancer cells were injected into the mammary fat pad of young female
mice. Six weeks later, mice were randomly divided into two diet groups: 1) mice with 10% corn oil
(rich in omega 6 fatty acids) in their food, 2) mice consuming a 10% fat diet that was enriched in n-
3 fatty acids. After two weeks on the diet, treatment with 200 cGy of IR every second day for four
treatments (total 800 cGy) was initiated on half of the mice from each diet group. Some mice in
each of the 4 groups were euthanized 24 hours after the end of IR while the remaining mice were
followed for 3 additional weeks. Tumor sections were stained for endothelial cells with CD31 and
PAS and for hypoxia inducible factor 1α (HIF-α).
Results: The tumor cortex within 100 microns of the well-vascularized capsule had little
vascularization. Blood vessels, capillaries, and endothelial pseudopods were found at areas greater
than 100 microns from the capsule (subcortex). Mice on the corn oil diet and treated with IR 24
hours previously or non-irradiated mice fed the n-3 diet had tumors with fewer blood vessels in
the subcortex and more endothelial pseudopods projecting into hypoxic (HIF- α positive) areas
than did mice from the non-irradiated corn oil fed group. The tumor growth rate of mice that
received IR or that were fed the n-3 fatty acid enriched diet was significantly slower than in the
mice fed the 10% corn oil diet. Harmful side effects were found only in the IR treated mice.
Conclusion: The omega-3 fatty acid enriched diet proved to be a safe means for retarding tumor
growth and vascularization.
Background
Animal and human epidemiological studies indicate that
increasing the consumption of omega-3 (n-3) fatty acids
versus intake of omega-6 (n-6) fatty acids decreased risk of
cancer [1-10]. Animal studies indicate that increased con-
sumption of n-3 fatty acids can slow the growth of cancer
xenografts and can increase the efficacy and decrease the
side effects of several chemotherapy agents [11-18].
Although consumption of an n-3 fatty acid enriched diet
has been demonstrated to reduce tumor growth in animal
xenografts, it is more likely to be used in combination
with chemotherapy or with ionizing radiation (IR)
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therapy in the treatment of cancer patients. More than half
of all cancer patients are given IR therapy during their
course of treatment [19]. It therefore seemed important to
determine the tumor growth retarding effects of IR and of
an n-3 fatty acid enriched diet both alone and in combi-
nation. As both IR [20,21] and dietary n-3 fatty acids
[22,23] are reported to suppress tumor angiogenesis, it
was reasoned that the combined use of these two treat-
ment modalities might have an additive effect on suppres-
sion of tumor growth and of angiogenesis. It was also
decided to test the idea that continued consumption of n-
3 fatty acids following a course of IR therapy might sup-
press regrowth of the IR treated tumor, perhaps by contin-
ued suppression of tumor angiogenesis.
The study reported here was therefore designed to investi-
gate the potential of omega-3 fatty acids in the diet to
inhibit growth and angiogenesis of a human breast cancer
xenograft and to compare the effects of: 1) a commonly
used course of IR involving exposure to 200 cGy every sec-
ond day for a total of 800 cGy, 2) an n-3 fatty acid
enriched diet, and 3) a combination of these two treat-
ment regimens on tumor growth, on tumor angiogenesis,
and on the side effects of each treatment regimen.
Although this study used whole body IR therapy, most IR
therapy of human patients is restricted to targeted regions
of the body to minimize general side effects of IR
treatment.
Our study results demonstrate the potential of the n-3
enriched fatty acid diet to inhibit tumor growth and ang-
iogenesis without harmful side effects.
Results
The four groups of mice are: 1) corn oil diet, no IR treat-
ment, 2) corn oil diet with IR treatment, 3) n-3 enriched
diet, no IR treatment, 4) n-3 enriched diet with IR
treatment.
Once the mice were divided into treatment groups, the
body weight of each mouse was measured every 3 to 4
days for the remainder of the experiment. As illustrated in
Fig. 1, the two groups that received IR therapy every sec-
ond day for 4 doses lost body weight beginning during IR
therapy and lasting for about 8 or 9 days. After comple-
tion of the IR therapy, the irradiated mice again began to
regain their weight toward the mean weight of the two
groups of mice not subjected to IR therapy. The mean
body weights of the groups of mice that did not receive IR
continuously increased until the end of the experiment
and were not different due to the diet.
Fig. 2 illustrates mean tumor volume for each of the four
groups of mice starting at the beginning of IR therapy. All
tumors in each of the four groups were less than 35 mm3
and the mean tumor sizes of all four groups were similar
at the start of IR treatment period. The mean growth rate
of tumors from the non-irradiated mice that received the
corn oil diet was significantly faster (p < 0.001) than that
of the other three groups of mice (Fig. 3). The tumor
growth rates of the remaining three groups of mice were
not significantly different from each other.
Tumor vascularization patterns were determined from
histological examination of midsections of PAS stained
tumors. Tumors with a volume greater than 35 mm3 dem-
onstrated a connective tissue capsule with blood vessels
(Fig. 4A). The cortical area of the tumors within about 100
µm of the capsule revealed few blood vessels while the
subcortical area greater than 100 µm from the capsule
showed evidence of blood vessels and capillaries with
many endothelial pseudopods extending away from the
capillaries (Fig. 4B&C). Immunohistochemical localiza-
tion of CD-31, used as a specific marker of endothelium,
demonstrated a positive reaction to blood vessels, capil-
laries, and pseudopods (Fig. 4D). Areas of tumor necrosis
were observed below the subcortical area (Fig. 4E&F).
Immunohistochemical localization of hypoxia-inducible
factor 1-α (HIF-α) revealed the subcortical area of the
tumor to contain HIF positive cells while the tumor cap-
sule, cortex and necrotic areas of the tumor demonstrate
no evidence of HIF. Thus, the area found to be HIF posi-
tive was enriched in endothelial pseudopods.
Ocular grid intercept counting was used to quantify tumor
vascularization in 8 µm thick PAS stained histological sec-
tions of the tumors. The numbers of ocular grid intercepts
were scored in the subcapsular regions of the tumor over
blood vessels and capillaries, endothelial pseudopods and
over the area with no indication of these structures. This
method has been shown to be a usable measure of vol-
ume density occupied by recognizable structures. The
results of the scoring of blood vessels and of endothelial
pseudopods in the subcortical regions of the tumors are
summarized in Fig. 5A&B. As illustrated in Fig. 5A&B, in
n-6 fed mice, the volume density of tumor blood vessels
was significantly decreased but the volume density of
tumor pseudopods was significantly increased at one day
after the last dose of irradiation compared to the n-6 fed
mice that did not receive IR. The blood vessel and pseudo-
pods volume densities of the tumors of IR treated corn oil
fed mice returned to the level of the non-irradiated corn
oil fed mice by 22 days after the last dose of irradiation.
However, in non-irradiated mice fed the n-3 fatty acid
enriched diet, the tumor blood vessel volume density was
significantly lower and the pseudopod volume density
was significantly higher than in the non-irradiated n-6 fed
mice. IR treatment did not significantly change the vol-
ume densities of either blood vessels or pseudopods in the
tumors of n-3 fed mice. Statistical analysis of the mean
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blood vessel volume density versus the pseudopod vol-
ume density revealed a significant correlation (r = 0.970,
Fig. 6) to an exponential fit. Thus, as the blood vessel vol-
ume density increased, the endothelial pseudopod vol-
ume density decreased.
Histological sections of viable areas of the tumor includ-
ing both the cortex and subcortical regions were scored for
number of metaphase figures. At least 1000 cancer cells
were counted in each H&E stained tumor. The results are
summarized in Fig. 7. The tumors of the corn oil fed group
not treated with IR had the highest metaphase index. The
tumors of groups of mice fed the n-3 fatty acids either with
or without IR treatments had significantly fewer met-
aphase figures than the tumors of mice that were fed the
corn oil diet but that were not treated with IR.
To assess side effects, mice were euthanized at both one
day and at 22 days after the last IR exposure. Data on liver
and spleen weights are summarized in Table 1, and data
on blood counts are summarized in Table 2. There were
no statistically significant differences in mean liver
weights among treatment groups at the earlier or later
kills. On the other hand, at one day after their last IR expo-
sure, the spleen weights of the two groups of mice that
received IR were significantly less than the spleen weights
of the groups that did not receive IR. The mean spleen
weights of the IR treated mice recovered to at least the
level of the non-irradiated corn oil fed mice by 22 days
after their last IR exposure.
There was a significant decrease in WBC, RBC, and plate-
lets counts attributed to IR at 1 day after the end of IR
treatment (Table 2). There were no significant differences
in WBC, RBC, and platelets counts attributed to the n-3
fatty acid diet. At 22 days after the end of the IR treatment,
the WBC and RBC counts in the two IR groups were not
quite as low as they were one day post IR but remained
significantly lower than that of the two non-irradiated
groups. Both IR groups had significantly higher platelet
Mean body weight of each group during the experimentFigure 1
Mean body weight of each group during the experiment. The two groups of mice that received gamma irradiation lost 
body weight during and for a few days after the course of exposure, but the body weights later recovered towards the weights 
of the two groups of mice not exposed to gamma irradiation.
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counts than any of the other groups by 22 days after the
end of IR therapy. Clearly, platelet counts have made a sig-
nificant compensatory rebound by this time.
Micronuclei are pieces of broken chromosomes left over
after the nucleus is extruded from a mature RBC and are
usually an indication of genetic damage. Statistical analy-
sis of micronuclei counts indicated no significant differ-
ences in the fraction of RBCs with micronuclei among any
of the four groups at either time of euthanasia.
Another measure of possible side effects was the scoring of
mitotic activity in the duodenal crypts. Dividing cells,
such as those in duodenal crypts, are particularly sensitive
to IR. Fig. 8 summarizes results of mitotic activity in the
duodenal crypts of mice euthanized one day after the end
of the IR therapy regimen. The metaphase index in the
duodenal crypts of the IR treated corn oil fed mice was sig-
nificantly lower than in the mice that did not receive IR,
indicating that dividing cells were killed. However, the
metaphase index in the duodenal crypts of the n-3 fed
mice that were IR treated was not significantly different
from that of the n-3 fed mice that were not IR treated.
Discussion
As expected, both IR and the n-3 fatty acid enriched diet
worked to suppress tumor growth. Statistical analyses of
the tumor growth rate data (Fig. 3) allow comparisons of
the efficacy of the four treatment procedures. The n-6 fed
mice not treated with IR had the fastest tumor growth rate.
The IR decreased the tumor growth rate by 90% in n-6 fed
mice. Compared to the non-irradiated n-6 fed mice, the n-
3 diet alone decreased the tumor growth rate by 66%
whereas the combination of the n-3 and IR decreased the
tumor growth rate by 78%. The tumor growth rates of the
three treated groups were not significantly different. Thus,
in this study, an n-3 fatty acid enriched diet alone was as
effective at decreasing the growth rate of MDA-MB 231 as
The effect on tumor growth of consumption of a diet containing 10% corn oil (n-6) or an n-3 enriched diet (n-3) with or with-out gamma irradiation (IR)Figure 2
The effect on tumor growth of consumption of a diet containing 10% corn oil (n-6) or an n-3 enriched diet (n-3) 
with or without gamma irradiation (IR). The tumors were all 35 mm3 or less at the start of treatment.
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was the n-6 fatty acid containing diet combined with radi-
ation. Radiation in combination with the n-3 diet was not
significantly more effective than the n-3 diet alone. Since
the IR treatment resulted in such good suppression of
tumor growth, we cannot determine if the n-3 fatty acid
diet increased the efficacy of the IR treatment or not. A dif-
ferent model in which IR treatment resulted in partial sup-
pression of tumor growth would be needed to make a
conclusion about the ability of n-3 fatty acids to increase
the efficacy of IR therapy.
What then are the possible factors involved in the
observed decrease in tumor growth rate due to the differ-
ent treatment protocols? The data on blood vessel volume
density indicate that either IR alone or the n-3 diet alone
were equally effective at reducing the density of blood
vessels in the tumors compared to that of the non-irradi-
ated corn oil fed group. The IR treatment alone in the corn
oil fed group suppressed tumor blood vessel volume den-
sity as assessed one day after the end of IR therapy. With
time, the volume density of blood vessels in the tumors of
the IR treated, corn oil fed group recovered to the level of
that of the tumors in the corn oil fed non-irradiated
group. However, the combination of the n-3 fatty acid diet
and the IR continued to suppress the density of blood ves-
sels in the tumors for 22 days after IR treatment ended.
The rapid proliferation of cancer cells requires angiogen-
esis to maintain oxygen and nutrient supplies to the grow-
ing tumor. Tumor cells that are far enough away (more
than 100 to 150 µm) from a blood vessel can become
hypoxic, which causes these tumor cells to produce HIF-α
and vascular endothelial growth factor (VEGF) [21]. The
VEGF then stimulates endothelial cells to sprout and pro-
duce pseudopods that project into hypoxic areas of the
tumor [21]. The endothelial sprouts and pseudopods
form vacuoles that fuse with capillary lumens, allowing
entry of blood cells. Other steps in angiogenesis include
degradation of the basement membrane surrounding
existing vessels, recruitment of smooth muscle and peri-
cyte cells, endothelial cell proliferation, lumen formation,
generation of a new basement membrane, fusion of newly
formed vessels and initiation of blood flow. The observed
inverse relationship between the volume densities of
blood vessels and of pseudopods, combined with the fact
that pseudopods are most abundant in the area of the
tumor most enriched in HIF-α, indicates that pseudopod
volume density is an indicator of hypoxic regions in the
tumor. Given this relationship, the increased pseudopod
volume density as observed in tumors suggests that the
subcortical areas are hypoxic. Tumor pseudopods were
significantly increased one day after IR therapy in the corn
oil fed mice. In the corn oil fed mice, the pseudopod vol-
ume density then decreased as the volume density of
blood vessels increased compared to the non-irradiated
corn oil fed mice during the 22 days recovery following
the end of IR therapy. The fact that the n-3 retarded recov-
ery of the tumor blood vessels but did not retard forma-
tion of pseudopods suggests that the n-3 diet is working to
retard angiogenesis at one or more of the later steps fol-
lowing pseudopod formation.
There are reports that an n-3 fatty acid enriched diet can
suppress mitosis and growth of breast and colon tumors
[1,6,9]. Thus, it was not surprising to find that the n-3 diet
also suppressed the metaphase index in viable areas of the
breast cancer tumors in this study.
Together the data reveal that consumption of the n-3 con-
taining diet resulted in a decrease in tumor growth rate,
cell proliferation (Fig. 7) and blood vessel volume density
(Fig. 5A). Hardman [24] has reviewed some of the possi-
ble molecular mechanisms involved in suppression of
tumor growth by addition of n-3 fatty acids to the diet.
The mechanisms involved in suppression of tumor
growth by an omega-3 fatty acid enriched diet include: 1)
decreased expression of cyclooxygenase-2, reducing ang-
iogenesis and decreasing cancer cell proliferation, 2) sup-
pression of nuclear factor κB activation and bcl-2
expression, allowing apoptosis of cancer cells, 3) suppres-
sion of the oncogenes AP-1 and ras, 4) induced differenti-
ation of the cancer cells, 5) reduction in aromatase activity
Tumor growth rates of each treatment groupFigure 3
Tumor growth rates of each treatment group. The 
growth rate is the slope of the linear regression (Fig. 2) of 
the tumor volumes over time. Different letters demonstrate 
significant differences as shown by ANOVA. Compared to 
the group fed the n-6 diet and not irradiated, either con-
sumption of the n-3 enriched diet or gamma irradiation sig-
nificantly reduced the tumor growth.
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Photomicrographs illustrating the pattern of the tumor vascular networkFigure 4
Photomicrographs illustrating the pattern of the tumor vascular network. A, B and C illustrate endothelial pseudo-
pods stained with PAS, D illustrates pseudopods stained with CD-31, a specific endothelial marker and E and F illustrate the 
localization of HIF. (A) The tumor capsule (left) reveals blood vessels. The cortex under the capsule reveals no blood vessels 
and few endothelial pseudopods while the subcortical area to the right has more pseudopods. (B) The subcortical area of the 
tumor reveals a small blood capillary with multiple endothelial pseudopods protruding at right angles into the tumor mass. (C) 
At higher magnification endothelial pseudopods are seen to branch. (D) The endothelial pseudopods react positively to the 
CD-31 specific endothelial marker. (E) Viable cell area can be seen beneath tumor capsule (left). Necrotic area can be seen to 
the right. (F) Enlarged subcortical area from E. In the subcortex, the brown stain localizes HIF in the hypoxic area between the 
viable and the necrotic tissue.
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that decreases estrogen levels, 6) inhibition of later steps
in the tumor angiogenesis process.
There has been concern that adding n-3 fatty acids to the
diet might increase radiation damage to the host. N-3 fatty
acids are more unsaturated than an n-6 fatty acid with the
same number of carbons. The double bonds are suscepti-
ble to radiation damage and when incorporated in cellu-
lar phospholipids could increase the susceptibility of a
cell to radiation induced lipid peroxidation. However, we
have shown that the production of endogenous antioxida-
tive enzymes is increased in normal cells (but not tumor
cells) when n-3 fatty acids are included in the diet [18].
This increase in endogenous antioxidative enzymes could
protect normal cells from oxidative damage. Damage to
the bone marrow due to the n-3 diet did not seem to be
increased based on either blood cell counts or numbers of
micronuclei. It appears that the lower basal mitotic index
in the duodenal crypts of n-3 fed mice may also have con-
tributed to protecting the intestine from radiation dam-
age. Irradiation is most damaging to proliferating cells. A
lower basal rate of proliferation might be expected to
result in less IR induced damage to cells with proliferative
capacity. The metaphase index of the duodenum crypts of
n-3 fed mice after IR is much closer to that of the non-irra-
Quantification of vascularization in the tumor subcortex of each treatme t groupFigure 5
Quantification of vascularization in the tumor sub-
cortex of each treatment group. The percent of areas 
(volume density) of blood vessels (A) and the percent of area 
of endothelial pseudopods (B) were determined using an 
ocular grid intercept counting method. The mean ± SEM of 
each treatment group is graphed. Columns that do not share 
a common letter within a graph are significantly different (p < 
0.01). Data from tumors collected at the early and late times 
of euthanasia of non-irradiated, n-6 or n-3 fed mice were 
pooled because there were no significant differences 
between these groups due to time of euthanasia.
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diated mice than in the n-6 fed mice after IR, indicating
either faster recovery or less initial killing by IR of prolif-
erative cells in the duodenum in the n-3 fed mice.
The whole body radiation of mice was expected to dem-
onstrate significant side effects within a day following the
eight-day course of IR therapy. The observed side effects
included significant decreases in WBC, RBC, and platelet
counts as well as loss of spleen weight. These measurable
side effects serve as reference for comparison with any side
effects of the n-3 enriched diet alone or in combination
with IR therapy. In this study, there was no evidence of
increased side effects due to the n-3 diet nor did it seem to
significantly lessen the measured side effects of IR therapy.
This failure of the n-3 diet to lessen the side effects of IR
therapy differs from past reports that omega-3 fatty acid
supplements ameliorated side effects of several chemo-
therapeutic agents [11-15]. Most of the observed side
effects with whole body irradiation are limited in human
patients by targeting of IR to tumorous regions.
The n-3 diet alone significantly suppressed tumor growth.
However, in the short term, the efficacy of the IR therapy
was not significantly greater in mice that consumed the n-
3 enriched diet than in the mice that consumed the corn
oil diet. Others have reported that the efficacy of radiation
Table 1: Omega-3 Fatty Acid Enriched Diet (n-3) and Gamma Irradiation Therapy (IR) on Liver and Spleen Weights (Means ± SEM)
Therapy Group n Liver weight (grams) Spleen weight (grams)
Early Kill1
n-6 5 0.94 ± 0.04 0.107 ± 0.009
n-6/IR 5 0.87 ± 0.07 0.031 ± 0.004
n-3 10 1.22 ± 0.06 0.150 ± 0.010
n-3/IR 5 1.05 ± 0.07 0.033 ± 0.003
Late Kill2
n-6 9 1.26 ± 0.07 0.166 ± 0.008
n-6/IR 20 1.17 ± 0.03 0.146 ± 0.008
n-3 20 1.19 ± 0.04 0.166 ± 0.014
n-3/IR 13 1.20 ± 0.05 0.240 ± 0.027
1Mice euthanized one day after last irradiation treatment.
2Mice euthanized 22 days after last irradiation treatment.
Table 2: Omega-3 Fatty Acid Enriched Diet (n-3) and Gamma Irradiation Therapy (IR) on Blood Counts, (means ± SEM)
Therapy Group n WBC × 103/µL RBC × 106/µL Platelets × 103/µL Micronuclei (%RBC)
Early Kill1
n-6 4 2.91 ± 0.83 9.08 ± 0.07 584 ± 76 1.3 ± 0.04
n-6/IR 4 0.11 ± 0.01 7.50 ± 0.16 389 ± 17 1.2 ± 0.03
n-3 7 2.02 ± 0.30 8.45 ± 0.12 634 ± 51 1.2 ± 0.03
n-3/IR 4 0.16 ± 0.03 7.66 ± 0.07 358 ± 78 1.5 ± 0.04
Late Kill2
n-6 8 1.85 ± 0.37 8.30 ± 0.14 551 ± 83 1.6 ± 0.06
n-6/IR 13 1.48 ± 0.32 7.06 ± 0.16 973 ± 98 1.1 ± 0.01
n-3 16 2.85 ± 0.42 8.31 ± 0.20 582 ± 61 1.3 ± 0.04
n-3/IR 10 0.92 ± 0.18 6.10 ± 0.40 918 ± 131 0.9 ± 0.03
1Mice euthanized one day after last irradiation treatment.
2Mice euthanized 22 days after last irradiation treatment.
Results of Statistical Analyses:
1. At one day after the end of irradiation therapy, there were significant decreases in WBC, RBC, and platelet counts due to the irradiation. There 
were no other significant differences at p < 0.01.
2. At 22 days after the end of irradiation therapy, WBC and RBC counts were still significantly decreased and there was a significant increase in 
platelet counts due to irradiation. There were no other significant differences at p < 0.01.
Cancer Cell International 2005, 5:12 http://www.cancerci.com/content/5/1/12
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therapy was increased in the presence of an n-3 containing
diet [25]. It is speculated that the n-3 oil diet reduced
blood vessel volume density, causing increased areas of
the tumor to become hypoxic, thus rendering these
hypoxic areas of the tumor less sensitive to the oxidative
damage of IR. Had our experiment continued longer than
three weeks after the radiation, the results might well have
been different. Angiogenesis suppression by the n-3 diet
would have continued to suppress growth of residual
tumors in the n-3 fed mice but residual tumors in the n-6
fed mice were stimulating angiogenesis and could have
resumed growth. In support of this idea, analyses of
tumor growth in the IR treated n-3 fed and n-6 fed mice
beginning 7 days after the end of radiation indicates that
there may be a resumption of growth of the residual
tumor in the n-6 fed mice but not in the n-3 fed mice. The
tumor growth rate (mean ± SD) from linear regression
analyses of the last four available data points of the n-6
fed, IR treated mice is 2.3 ± 0.5 mm3/day, a significant (p
60; 0.05) positive growth rate. However, the tumor
growth rate (mean ± SEM) of the n-3 fed, IR treated mice
for the last four data points is -1.0 ± 1.0 mm3/day, a rate
that is not significantly (p = 0.5) different from 0. Due to
the few points, these tumor growth rates are not quite sig-
nificantly different (p = 0.07) yet the data does suggest
that in a longer term study, n-3 may provide a better treat-
ment advantage than is indicated by the results of this
study.
Conclusion
In conclusion, an omega-3 fatty acid enriched diet was
found to significantly reduce the growth rate and angio-
genesis of a human breast cancer xenograft without evi-
dence of harmful side effects.
Methods
All animal use and care procedures were approved by the
Institutional Animal Care and Use Committees of the
University of Texas Health Science Center at San Antonio
and of the Pennington Biomedical Research Center. The
human breast cancer cell line MDA-MB-231 was obtained
from the American Type Culture Collection. The cell lines
were cultured in McCoys's 5A medium supplemented
with pyruvate, vitamins, amino acids, antibiotics, and
10% fetal bovine serum [26]. The MDA-MB-231 cells were
harvested from exponential cultures and inoculated at 2 ×
106cells/inoculum in the inguinal mammary fat pad area
of 160 female athymic nude mice, 6 weeks of age
(purchased from the Harlan Sprague Dawley, Inc., Indian-
apolis, IN). The animals were housed under pathogen-free
conditions and fed an AIN-76 semipurified diet slightly
altered to contain 10% w/w corn oil during the initial
tumor growth period. Growth of each xenograft was mon-
itored three times per week by externally measuring
tumors in three dimensions using digital calipers.
Xenograft volume (V) was determined by the following
equation: V = (L × W × D) × 0.5, where L is the length, W
is the width and D is the depth of a xenograft. When the
tumors reached an average diameter of about 3 mm after
5 weeks, the mice were divided into 2 groups such that the
mean and median of tumor volume of the groups were
closely matched.
Half of the mice fed the 10% w/w corn oil diet for the
remainder of the study, half of the mice were placed on
the experimental diet that contained 5% w/w n-3 fatty
acids supplement (AAFA, Incell, Corp., LLC, San Antonio,
TX) and 5% w/w canola oil. Corn oil is 61% linoleic acid
(18:2n-6) and about 1% n-3 fatty acid thus it provides pri-
marily n-6 FAs. The 5% w/w canola oil was used as the
source of essential n-6 FAs in the n-3 diet. Canola oil is
20% linoleic acid and it also contains about 10% alpha-
linolenic acid (18:3n-3). Five percent w/w n-3 FAs
supplement (AAFA) containing 6% n-6 fatty acid and
61% total n-3 fatty acids was added to greatly increase the
n-3 content of this diet. The total w/w composition of the
n-6 diet was 0.1% n-3 FAs and 6.1% n-6 FAs with an n-3/
n-6 ratio of 0.1. The total w/w composition of the n-3 diet
was 3.65% n-3 FAs and 1.3% n-6 FAs with an n-3/n-6 FAs
ratio of 2.8:1. These diets provided large differences in the
Number of metaphase figures per midaxial histological sec-tion of duodenal cryptsFigur  8
Number of metaphase figures per midaxial histologi-
cal section of duodenal crypts. Mice were euthanized 
one day after the last gamma irradiation exposure. Column 
height indicates mean ± SEM. The columns that do not share 
a common letter are significantly different. The number of 
metaphase figures in the duodenal crypts of mice that 
received IR or that consumed the n-3 diet was significantly 
less than in the non-irradiated corn oil fed mice.
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fatty acids thought to be associated with cancer growth,
linoleic acid and n-3 FAs.
Half of the tumor-bearing mice of each diet group
received a cumulative dose of 800 cGy of IR (200 cGy each
second day for 4 cycles). The 200 cGy/day dosage is based
on the results from a preliminary dose response study
using the same mouse model and on the fact that 180 to
250 cGy/day is the commonly used acute dose for radio-
therapy of humans. About 815 cGy whole body radiation
is the LD50/30 for mice (50% lethal within 30 days). Mice
were transferred to a circular cage with individual com-
partments for each mouse during irradiation. Mice were
irradiated in a 137Cs Gamma Cell-40 Irradiator (Atomic
Energy of Canada) facility in our Department of
Radiology. A dosimetric analysis for this instrument is
performed monthly for calculation of a precise 200 cGy
exposure. Mice were euthanized at one day or 22 days
after the last radiation treatment.
Mice were deeply anesthetized using a ketamine/rompun
mixture prepared by the UTHSCSA Laboratory Animal
veterinarian, cervically dislocated, then were exsanguin-
ated by cardiac puncture. Blood was collected into an
EDTA containing microtube for complete blood counts.
The tumor, duodenum, spleen and liver were removed at
the time of euthanasia. Samples of the duodenum and the
tumor were fixed in Omni Fix II (Mt. Vernon N.Y.) and
paraffin embedded. Embedded tissues were cut 4 µm or 8
µm thick, cut sections were placed on microscope slides
then deparaffinized and stained with hematoxylin and
eosin or with periodic acid-Schiff (PAS) for
morphological analysis. Additional sections were pre-
pared for immunohistochemistry.
To determine the effect of treatment on tumor angiogen-
esis, we measured the vascularity of excised tumors.
Tumor tissues were fixed and embedded in paraffin. Mid
tumor sections (8 µm thick) were cut from the embedded
tissue and stained with periodic acid Schiff (PAS). Sec-
tions were examined by light microscopy. CD31 immu-
nostaining for mouse blood vessels on 4 µm thick sections
was performed by incubating tumor sections with a rat
antimouse CD-31 (PECAM-1) monoclonal antibody
(PharMingen) at 5 µg/ml for 30 min at 37°C. Sections
were then incubated with a biotin-labeled goat anti-rat
IgG (Zymed; 1:200 dilution) for 30 min at room temper-
ature, followed by ABC reagent kit (Vector Laboratories)
for 30 min at room temperature. Color reaction was per-
formed with 3, 3'-diaminobenzidine (Vector
Laboratories) and counterstained with hematoxylin.
Hypoxia-inducible factor-1 alpha (HIF-1α) immunohis-
tochemistry was done following the instruction for anti-
gen retrieval (Biogenex protocol) and iso-IHC (inno-
Genex Mouse-on-Mouse iso-IHC kit) with these changes:
Dewaxing was with 3 changes of xylene, 10 minutes/
change. Rehydration in 100%, 90%, and 70% ethanol for
10 minutes each. Initial dilution of the antibody was
1:200. Stressgen anti-HIF-1 alpha, product # OSA-601,
was the antibody used. All sections were coded, treated as
above and the extent of blood vessels, endothelial cell
pseudopods and total area volume density was scored
using an ocular grid. The number of grid line intercepts
over blood vessels and endothelial pseudopods gave a
measure of the total volume density of these structures.
A blood cell counter with veterinary pack was used for
counts of red cells, white cells and platelets in EDTA anti-
coagulated blood of the mice. Our Laboratory Animal
Resources division performed this test. Micronuclei
counts were determined on thin smears of whole blood.
Blood smears were stained with 0.1% acridine orange in
phosphate buffered saline (pH 7.4) for 10 seconds. Slides
were then examined for the presence of micronuclei using
a fluorescent microscope and a 100X oil immersion objec-
tive. At least 1000 acridine orange stained red blood cells
were counted and the percentage of erythrocytes contain-
ing micronuclei was determined [27].
Fixed specimens of duodenum were trimmed, processed
and oriented for paraffin embedding. Four µm thick sec-
tions of the paraffin blocks were mounted on slides.
Complete midaxially sectioned crypts on H&E stained
slides were selected for analyses. Complete crypts were
defined as those with: 1) the crypt base at the muscularis
mucosa, 2) an open lumen from mouth to base and 3) a
single column of epithelial cells up each side of the crypt.
The numbers of metaphase figures per midaxial crypt sec-
tion were counted for 10 crypts of each mouse.
SAS computer software was used for statistical analyses of
numerical data. Tests for normality (basic statistics) were
used on each data set. One-way and two-way analyses of
variance followed by Student-Newman-Keuls multiple
range tests, as appropriate, was used to determine if there
were statistically significant (p ≤ 0.05) differences in any
measured parameter due to the therapies. Prism™ (Graph-
pad Software, Inc.) was used for statistical analyses of
tumor growth data. The mean growth rate for each group
was determined using least squares linear regression anal-
ysis of mean tumor volume with time. Analyses of vari-
ance of the slopes of the linear regression (growth rate)
were used to determine statistical differences in mean
growth rates between treatment groups.
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